Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Shalini Dalal Image

      Shalini Dalal, MD

      Department of Palliative, Rehabilitation and Integrative Medicine, Division of Cancer Medicine

      Present Title & Affiliation

      Primary Appointment

      Professor, Palliative Care and Rehabilitation Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

      Dual/Joint/Adjunct Appointment

      Professor, Palliative Care and Rehabilitation Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

      Education & Training

      Degree-Granting Education

      1989Armed Forces Medical College, Pune, IN, MBBS in Medicine

      Postgraduate Training

      2003-2004Clinical Fellowship, Symptom Control and Palliative Care, The University of Texas MD Anderson Cancer Center, Houston, Texas
      1994-1997Clinical Residency, Internal Medicine, Prince George's Hospital Center, Cheverly, Maryland
      1990-1990Clinical Internship, Medicine, Army Hospital, New Delhi
      1989-1989Clinical Internship, Station Health Organization, Pune

      Licenses & Certifications

      2021American Board of Preventive Medicine
      2010American Board of Hospice and Palliative Medicine
      2004Texas Medical License
      1997American Board of Internal Medicine

      Experience & Service

      Faculty Academic Appointments

      Associate Professor, Palliative Care and Rehabilitation Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2011 - 2018

      Adjunct Member, The University of Texas Graduate School of Biomedical Sciences, Houston, TX, 2010 - 2011

      Assistant Professor, Department of Palliative Care and Rehabilitation Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2004 - 2011

      Administrative Appointments/Responsibilities

      Quality and Safety Officer, The University of Texas MD Anderson Cancer Center, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019 - Present

      Member, Department of Palliative Care Monthly Rotation Scheduling Committee, Palliative Care and Rehabilitation Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2012 - Present

      Member, Board Review Planning Committee, Intensive Board Review in Hospice and Palliaive Medicine, Palliative Care and Rehabilitation Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2007 - Present

      Co-Director - Outpatient Cachexia Clinic, Palliative Care and Rehabilitation Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2006 - 2011

      Other Professional Positions

      Quality and Safety Officer, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019 - Present

      Member, National Institute of Health National Cancer Institute Physicians Data Query (PDQ) Supportive and Palliative Care Advisory Board, Washington, DC, 2009 - Present

      Panel Member, National Comprehensive Cancer Network, Washington, DC, WA, 2009 - Present

      Member, National Cancer Institute Physicians Data Query (PDQ) Supportive Care Editorial Board, Washington, DC, 2009 - 2013

      Staff Physician, Veterans Affairs Puget Sound Health Care System, Tacoma, WA, 2001 - 2003

      Staff Physician, Veterans Affairs Medical Center, Fargo, ND, 1998 - 2001

      Physician, Private Practice, Atlanta, GA, 1997 - 1998

      Captain/Medical Officer, 1990 - 1994

      Extramural Institutional Committee Activities

      Member, Medication Diversion Prevention Program, The University of Texas MD Anderson Cancer Center, 2018 - Present

      Chair, Pain Task Force, The University of Texas MD Anderson Cancer Center, 2018 - Present

      Member, Psychosocial Council, The University of Texas MD Anderson Cancer Center, 2014 - 2015

      Vice Chair, Institutional Review Board II, The University of Texas MD Anderson Cancer Center, 2012 - 2019

      Faculty Senator, Faculty Senate, The University of Texas MD Anderson Cancer Center, 2009 - 2013

      Member, Institutional Review Board II, The University of Texas MD Anderson Cancer Center, 2009 - 2012

      Member, Failure Mode & Effects Analysis (FMEA): Reducing the Risk of Patient Harm with Opiates, The University of Texas MD Anderson Cancer Center, 2008 - Present

      Project Leader, Institutional Cancer Pain Management Guidelines, The University of Texas MD Anderson Cancer Center, 2008 - Present

      Member, Midlevel Schedule II Workgroup, The University of Texas MD Anderson Cancer Center, 2008 - 2012

      Member, Pharmacy & Therapeutics Committee, The University of Texas MD Anderson Cancer Center, 2008 - 2010

      Member, Hospice and Palliative Medicine Intensive Physician Board Review Planning Committee, The University of Texas MD Anderson Cancer Center, 2007 - 2010

      Member, Cancer Survivorship Research Committee, The University of Texas MD Anderson Cancer Center, 2007 - 2009

      Member, Clinical Effectiveness Committee, The University of Texas MD Anderson Cancer Center, 2007 - 2009

      Associate Member, Institutional Review Board II, The University of Texas MD Anderson Cancer Center, 2006 - 2009

      Member, Advance Directive Project Team, The University of Texas MD Anderson Cancer Center, 2006 - 2007

      Editorial Activities

      Member of Editorial Review Board, National Cancer Institute: PDQ Supportive and Palliative Care Editorial Board, 2009 - 2013

      Editor, Up to Date Peer Review Topics, 2005 - Present

      Editor/Service on Editorial Board, Pain Management and Relief: Assessment and Treatment, 2005 - Present

      Honors & Awards

      2012Apple Award, The University of Texas MD Anderson Cancer Center
      2010National Institute of Health Award Merit - PDQ Supportive and Palliative Care Editorial Board, National Cancer Institute, National Institute of Health

      Professional Memberships

      Indo-American Cancer Association

      2011 - Present

      American Association of Physicians of Indian Origin

      2011 - 2012

      National Comprehensive Cancer Network

      2009 - Present

      Focus Group on cancer cachexia classification for the European Palliative Care Research Collaborative

      2008 - Present

      Public Responsibility in Medicine and Research

      2007 - Present

      European Association for Palliative Care

      2007 - Present

      American Society of Clinical Oncology

      2007 - Present

      Multinational Association of Supportive Care in Cancer

      2006 - Present

      American Medical Association

      2004 - Present

      American College of Physicians

      2004 - Present

      Harris County Medical Society

      2004 - Present

      Selected Presentations & Talks

      Local Presentations

      1. 2025. Pain Task Force: Gauging the Safety, Quality, and Regulatory Standards of the Cancer Pain Experience at a Comprehensive Cancer Center. Conference. 7th Interdisciplinary Pain & Opioid Seminar. Houston, TX, US.
      2. 2024. Optimizing the Cancer Pain Experience of Hospitalized Patients: A Collaborative Effort. Conference. 6th Interdisciplinary Pain & Opioid Crisis Seminar. Houston, Texas, US.
      3. 2023. Assessment and Management of Cancer Pain. Conference. Assessment and Management of Cancer Pain. Houston, TX, US.
      4. 2018. Introduction of New Pain Task Force / Institutional Patient Safety Committee. Conference. Introduction of New Pain Task Force / Institutional Patient Safety Committee. Houston, TX, US.
      5. 2017. Pain Management Considerations When Transitioning Care. Conference. Pain Management Considerations When Transitioning Care. Houston, TX, US.
      6. 2010. Palliative Care and Hospice: Looking Through the Looking Glass. Conference. Palliative Care and Hospice: Looking Through the Looking Glass. Houston, TX, US.
      7. 2008. Introduction to Palliative Care. Conference. Introduction to Palliative Care. Houston, TX, US.

      Regional Presentations

      1. 2008. Cancer Symptoms: Multi Symptom Assessment and Management Approaches. Conference. Cancer Symptoms: Multi Symptom Assessment and Management Approaches. Fargo, ND, US.

      National Presentations

      1. 2023. Referrals to supportive/palliative care service among hospitalized patients with cancer who reported severe pain at a tertiary cancer center. Conference. Referrals to supportive/palliative care service among hospitalized patients with cancer who reported severe pain at a tertiary cancer center.
      2. 2021. Meet the Professor Case Presentation/Discussion. Conference. University of Texas MD Anderson Cancer Center. Houston, TX, US.
      3. 2021. Opioids for Pain Management. Conference. University of Texas MD Anderson Cancer Center. Houston, TX, US.
      4. 2021. Nausea/Constipation/Bowel Obstruction. Conference. University of Texas MD Anderson Cancer Center. Houston, TX, US.
      5. 2019. Frequency and Severity of Pain in Hospitalized Cancer Patients at a Tertiary Cancer Center. Conference. Frequency and Severity of Pain in Hospitalized Cancer Patients at a Tertiary Cancer Center. San Francisco, CA, US.
      6. 2019. Ketamine and Cancer Pain. Conference. University of Texas MD Anderson Cancer Center. Houston, TX, US.
      7. 2019. Nausea/Constipation/Bowel Obstruction. Conference. University of Texas MD Anderson Cancer Center. Houston, TX, US.
      8. 2019. Opioids for Pain Management. Conference. University of Texas MD Anderson Cancer Center. Houston, TX, US.
      9. 2019. Meet the Professor - case presenttion - round table disucssion. Conference. University of Texas MD Anderson Cancer Center. Houston, TX, US.
      10. 2018. Optimizing Pain Management: Guidelines and Taskforce. Conference. University of Texas MD Anderson Cancer Center. Houston, TX, US.
      11. 2018. Narcan or Narcant?. Conference. University of Texas MD Anderson Cancer Center. Houston, TX, US.
      12. 2018. Palliative Care Emergencies. Conference. University of Texas MD Anderson Cancer Center. Houston, TX, US.
      13. 2018. Nausea/Constipation/Bowel Obstruction. Conference. University of Texas MD Anderson Cancer Center. Houston, TX, US.
      14. 2017. Cancer Pain Drug Therapies: Current and Emerging Trends. Conference. University of Texas MD Anderson Cancer Center. Houston, TX, US.
      15. 2017. Nausea/Constitution/Bowel Obstruction. Conference. University of Texas MD Anderson Cancer Center. Houston, TX, US.
      16. 2017. How Adherence to Guidelines Influences the Cost Effectiveness of Supportive Care Interventions. Conference. How Adherence to Guidelines Influences the Cost Effectiveness of Supportive Care Interventions. Washington D.C, WA, US.
      17. 2016. Nausea, Constipation, Bowel Obstruction. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
      18. 2016. Pain Management: Adjuvant Medications in Pain Management. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
      19. 2014. Symptom Management. Conference. 11th International Conference of the Society for Integrative Oncology. Houston, TX, US.
      20. 2014. Cachexia, Nausea, Vomiting, Bowel Obstruction, and Constipation. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
      21. 2014. Palliative Care Emergencies. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
      22. 2014. Association between abdominal fat distribution and clinical outcomes in postmenopausal women with operable stage breast cancer. Conference. ASCO. Miami, FL, US.
      23. 2013. Palliative Care Emergencies. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
      24. 2013. Cachexia, Nausea, Vomiting, Bowel Obstruction, Constipation. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
      25. 2012. Parenteral hydration (PH) in advanced cancer patients: A multi-center, double-blind, placebo-controlled randomized trial. (Poster Discussion Session: Patient and Survivor Care). Conference. Parenteral hydration (PH) in advanced cancer patients: A multi-center, double-blind, placebo-controlled randomized trial. (Poster Discussion Session: Patient and Survivor Care). Chicago, IL, US.
      26. 2012. Patient-Physician Communication about Code Status Preferences: A Randomized Controlled Trial. Conference. Patient-Physician Communication about Code Status Preferences: A Randomized Controlled Trial. Chicago, IL, US.
      27. 2012. Temporal versus probabilistic approach to survival estimation: Physician's accuracy over time. Conference. Temporal versus probabilistic approach to survival estimation: Physician's accuracy over time. Chicago, IL, US.
      28. 2012. A multi-center, double-blind, placebo-controlled randomized trial. Conference. A multi-center, double-blind, placebo-controlled randomized trial. Chicago, IL, US.
      29. 2012. Dexamethasone (DM) for cancer related fatigue: A double-blinded, randomized, placebo-controlled trial. Conference. Dexamethasone (DM) for cancer related fatigue: A double-blinded, randomized, placebo-controlled trial. Chicago, IL, US.
      30. 2012. Clinical signs of dying in cancer patients. Conference. Clinical signs of dying in cancer patients. Chicago, IL, US.
      31. 2011. Personalized Pain Goal - What are the Latest Guidelines for Pain Management for End of Life Care. Conference. 15th Annual Interdisciplinary Conference on Supportive Care, Hospice and Palliative Medicine. Houston, TX, US.
      32. 2011. Achievement of personalized pain goal (PPG) in cancer patients referred to a Supportive Care Clinic. Conference. Achievement of personalized pain goal (PPG) in cancer patients referred to a Supportive Care Clinic. Chicago, IL, US.
      33. 2011. Achievement of Personalized Pain Goal (PPG) in Cancer Patients Referred to a Supportive-Care Clinic (Poster). Conference. Achievement of Personalized Pain Goal (PPG) in Cancer Patients Referred to a Supportive-Care Clinic (Poster). Chicago, IL, US.
      34. 2010. Impact of change in service name from "Palliative" to "Supportive" care on patient referral at a comprehensive cancer center (Poster Presentation). Conference. Impact of change in service name from "Palliative" to "Supportive" care on patient referral at a comprehensive cancer center (Poster Presentation). Chicago, IL, US.
      35. 2009. Clinical Findings and interventions in cancer patients referred to a cachexia clinic (CC) (Poster). Conference. Clinical Findings and interventions in cancer patients referred to a cachexia clinic (CC) (Poster). Orlando, FL, US.
      36. 2009. Association between inflammatory markers, symptom burden, hypogonadism and survival in cancer patients with cachexia (Poster). Conference. Association between inflammatory markers, symptom burden, hypogonadism and survival in cancer patients with cachexia (Poster). Orlando, FL, US.
      37. 2009. Association between hypogonadism, inflammatory marker, symptom burden, and survival in cancer patients with cachexia: A preliminary report (Poster Presentation). Conference. Association between hypogonadism, inflammatory marker, symptom burden, and survival in cancer patients with cachexia: A preliminary report (Poster Presentation). Orlando, FL, US.
      38. 2008. Keynote Speaker, Anorexia and Cachexia: New Thinking New Choices. Conference. Enhancing Care : A new look at pain & symptom management. Moorhead, MN, US.
      39. 2008. Keynote Speaker, Advances in Symptom Management and Research. Conference. Enhancing Care: A new look at pain & symptom management. Moorhead, MN, US.
      40. 2008. Gender based differences in the relationship between body composition alterations, as measured by computerized tomography (CT) imaging, and survival, in locally advanced pancreatic cancer (LAPC) receiving chemoradiation (Poster Presentation). Conference. Gender based differences in the relationship between body composition alterations, as measured by computerized tomography (CT) imaging, and survival, in locally advanced pancreatic cancer (LAPC) receiving chemoradiation (Poster Presentation). Houston, TX, US.
      41. 2008. Differential impact of changes in muscle tissue (MT) and adipose tissue (AT) on survival in men and women with locally advanced pancreatic cancer (LAPC) receiving chemoradiation (CRT) (Poster Presentation). Conference. Differential impact of changes in muscle tissue (MT) and adipose tissue (AT) on survival in men and women with locally advanced pancreatic cancer (LAPC) receiving chemoradiation (CRT) (Poster Presentation). Chicago, IL, US.
      42. 2008. Relationship between inflammation and symptom distress in cachectic cancer patients assessed at a cachexia clinic in a comprehensive cancer center. Conference. Relationship between inflammation and symptom distress in cachectic cancer patients assessed at a cachexia clinic in a comprehensive cancer center. Houston, TX, US.
      43. 2007. The effect of methadone on the QTc interval in advanced cancer patients (Poster Presentation). Conference. The effect of methadone on the QTc interval in advanced cancer patients (Poster Presentation). Chicago, IL, US.
      44. 2007. Secondary vs. primary cachexia in patients with advanced cancer (Poster Presentation). Conference. Secondary vs. primary cachexia in patients with advanced cancer (Poster Presentation). Chicago, IL, US.
      45. 2006. Hospital Based Palliative Care: Bridges, Boundaries and Benefits. Conference. Cancer Update. Wichita Falls, TX, US.
      46. 2006. Outpatient Palliative Care Clinic: Strategies, Benefits and Challenges. Conference. Outpatient Palliative Care Clinic: Strategies, Benefits and Challenges. Nashville, TN, US.

      International Presentations

      1. 2023. Association Between Uncontrolled Pain on Hospital Discharge Day and 30-Day Unplanned Hospital Readmissions at A Teritiary Cancer Hospital. Conference. Association Between Uncontrolled Pain on Hospital Discharge Day and 30-Day Unplanned Hospital Readmissions at A Teritiary Cancer Hospital, JP.
      2. 2023. Management of nausea, constipation, and bowel obstruction in cancer patients. Conference. It’s only palliative care, but I like it …, IT.
      3. 2018. Intravenous Naloxone Utilization Among Hospitalized Cancer Patients on Opioids at a Tertiary Cancer Center. Conference. Intravenous Naloxone Utilization Among Hospitalized Cancer Patients on Opioids at a Tertiary Cancer Center. Vienna, AT.
      4. 2017. The impact of race/ethnicity on the prognostic associations between general and visceral obesity and breast cancer outcomes. Conference. The impact of race/ethnicity on the prognostic associations between general and visceral obesity and breast cancer outcomes. Rome, IT.
      5. 2017. Gastrointestinal Symptoms in Advanced Cancer Patients. Conference. Gastrointestinal Symptoms in Advanced Cancer Patients. Palermo, Sicily, IT.
      6. 2015. Attitudes and Beliefs toward Supportive and Palliative Care Referral among Hematologic and Solid Tumor Oncology Specialists (Poster). Conference. Attitudes and Beliefs toward Supportive and Palliative Care Referral among Hematologic and Solid Tumor Oncology Specialists (Poster). Copenhagen, DK.
      7. 2015. Integration of Palliative Care Services with Oncology Practice: What’s in a Name?. Conference. Integration of Palliative Care Services with Oncology Practice: What’s in a Name?. Copenhagen, DK.
      8. 2012. Assessment of personalized pain goal (PPG) in cancer patients referred to a supportive-care clinic at a comprehensive cancer center. Conference. Assessment of personalized pain goal (PPG) in cancer patients referred to a supportive-care clinic at a comprehensive cancer center. Trondheim, NO.
      9. 2012. Quality of Reporting of the Supportive and Palliative Oncology Literature. Conference. Quality of Reporting of the Supportive and Palliative Oncology Literature. Trondheim, NO.
      10. 2012. Assessment of Personalized Pain Goal (PPG) in Cancer Patients Referred to the Supportive Care Clinic for Pain Management (Poster Presentation-P283). Conference. Assessment of Personalized Pain Goal (PPG) in Cancer Patients Referred to the Supportive Care Clinic for Pain Management (Poster Presentation-P283). Trondheim, NO.
      11. 2011. Predictors of in-hospital mortality in advanced cancer patients admitted to an acute palliative care unit (APCU): A prospective study (Oral Abstract). Conference. Predictors of in-hospital mortality in advanced cancer patients admitted to an acute palliative care unit (APCU): A prospective study (Oral Abstract). Athens, GR.
      12. 2011. The accuracy of clinical prediction of survival (cps) for advanced cancer patients: the role of profession and probability question (Poster). Conference. The accuracy of clinical prediction of survival (cps) for advanced cancer patients: the role of profession and probability question (Poster). Athens, GR.
      13. 2011. Achievement of Personalized Pain Goal (PPG) in Cancer Patients Referred to a Supportive Care Clinic (Poster). Conference. Achievement of Personalized Pain Goal (PPG) in Cancer Patients Referred to a Supportive Care Clinic (Poster). Athens, GR.
      14. 2011. Vitamin D Deficiency and Endocrine Abnormalities in Advanced Care Patients (Oral Abstract). Conference. Vitamin D Deficiency and Endocrine Abnormalities in Advanced Care Patients (Oral Abstract). Athens, GR.
      15. 2011. Secondary Cachexia in Patients with Advanced Cancer (Oral Presentation). Conference. Secondary Cachexia in Patients with Advanced Cancer (Oral Presentation). Vancouver, British Columbia, CA.
      16. 2010. "Does a Name Change from "Palliative" to "Supportive" Care have an Impact on Patient Referrals? A Retrospective Data Review at a Comprehensive Cancer Center (Poster Presentation). Conference. "Does a Name Change from "Palliative" to "Supportive" Care have an Impact on Patient Referrals? A Retrospective Data Review at a Comprehensive Cancer Center (Poster Presentation). Vancouver, CA.
      17. 2009. Chemotherapy Induced and Chronic Emesis in Patients with Advanced Cancer (Poster Presentation). Conference. III Iberoamerican Symposium in Treatment Support and Palliation in Oncology. Madrid, ES.
      18. 2009. Association between inflammatory markers, symptom burden, hypogonadism and survival in cancer patients with cachexia (Poster). Conference. Association between inflammatory markers, symptom burden, hypogonadism and survival in cancer patients with cachexia (Poster). Rome, IT.
      19. 2009. Findings and Interventions in Cancer Patients referred to a Cachexia Clinic (Poster Presentation). Conference. Findings and Interventions in Cancer Patients referred to a Cachexia Clinic (Poster Presentation). Rome, IT.
      20. 2009. Impact of a Multidisciplinary Cachexia Clinic at a Tertiary Cancer Hospital on Patient Related Outcomes (Poster Presentation). Conference. Impact of a Multidisciplinary Cachexia Clinic at a Tertiary Cancer Hospital on Patient Related Outcomes (Poster Presentation). Rome, IT.
      21. 2008. Gender based differences in the relationship between body composition alterations as measured by computerized tomography (CT) Imaging and survival in locally advanced pancreatic cancer (LAPC) receiving chemoradiation (Oral Presentation). Conference. Gender based differences in the relationship between body composition alterations as measured by computerized tomography (CT) Imaging and survival in locally advanced pancreatic cancer (LAPC) receiving chemoradiation (Oral Presentation). Surrey, British Columbia, CA.
      22. 2008. Association between CRP and symptoms in patients assessed at a cachexia clinic (CC) with involuntary weight loss (IWL) (Poster Presentation). Conference. Association between CRP and symptoms in patients assessed at a cachexia clinic (CC) with involuntary weight loss (IWL) (Poster Presentation). Trondheim, NO.
      23. 2007. Symptom burden severity in patients with advanced solid vs. hematological malignancies (Poster Presentation). Conference. Symptom burden severity in patients with advanced solid vs. hematological malignancies (Poster Presentation). St. Gallen, CH.
      24. 2007. Cachexia syndrome symptom cluster in patients referred to a specialized cachexia clinic in a comprehensive cancer center (Poster Presentation). Conference. Cachexia syndrome symptom cluster in patients referred to a specialized cachexia clinic in a comprehensive cancer center (Poster Presentation). St. Gallen, CH.
      25. 2007. The effects of Cachexia treatment on symptoms weight and fat-free mass in cancer patients (Poster Presentation). Conference. The effects of Cachexia treatment on symptoms weight and fat-free mass in cancer patients (Poster Presentation), ZA.

      Formal Peers

      1. 2013. Pain Management At The End of Life. Invited. Houston, TX, US.
      2. 2010. Palliative Care of Today. Invited. Cape Girardeau, MO, US.
      3. 2008. "Advances in Symptom Control". Invited. Topeka, KS, US.
      4. 2008. "Palliative Care: Boundaries, Bridges and Challenges". Invited. Topeka, KS, US.
      5. 2008. "I’m Tired! Managing Cancer Related Fatigue". Invited. Houston, TX, US.
      Read More
      Less

      Grant & Contract Support

      Date: 2017 - Present
      Title:A Phase II Study of TAK-228 (MLN0128) Patients with Advanced Cancers with P13K/MTOR Pathway Alterations
      Funding Source:NIH/NCI
      Role:Collaborator
      Date: 2013 - 2015
      Title:Association between body composition and docetaxel-induced toxicity in male prostate cancer patients receiving single agent docetaxel therapy
      Funding Source:NIH/NCI
      Role:Collaborator
      Date: 2008 - 2010
      Title:The effects of Dehydroepiandrosterone (DHEA) on cachexia symptom cluster in advanced cancer patients
      Funding Source:NIH/NCI
      Role:PI
      Title:Relationship between immune, endocrine and body composition alterations in male and female patients with pancreatic cancer: Impact on clinical outcomes
      Funding Source:Other
      Role:PI

      Selected Publications

      Peer-Reviewed Articles

      1. Amaram-Davila, JS, Vega, MF, Bramati, PS, Stewart, HA, Aceves, M, Dalal, S, Reddy, AS, Azhar, A, Reddy, SK, Bodurka, DC, George, MC, Aiss, MA, Bruera, E. From Emails to EMR. Cancers 17(17), 2025. e-Pub 2025. PMID: 40940972.
      2. Dev R, Bramati P, Delgado Guay MO, Fellman B, Azhar A, Tang M, Tennison J, Becerra J, Admane S, Dalal S, Hui D, Fabbro ED, Bruera E. Malnutrition Risk and the Psychological Burden of Anorexia and Cachexia in Patients With Advanced Cancer. JCSM 8(1), 2025. e-Pub 2025.
      3. Amaram-Davila, JS, Vega, MF, Kim, MJ, Dalal, S, Dev, R, Tanco, KC, Admane, S, De Moraes, AR, Thomas, L, Shelal, Z, Gogineni, M, Bramati, PS, Urbauer, D, Hui, D, Arthur, JA, Haider, A, Bruera, E, Reddy, AS. Perceptions Toward Naloxone Among Patients With Cancer Receiving Opioids. Journal of Pain and Symptom Management 68(6):e500-e507, 2024. e-Pub 2024. PMID: 39218123.
      4. Muthu M, Dalal S, George M, Clavijo CS, Lenz C, Nortje N. The importance of facilitating goal-concordant care (GCC) in a pandemic: the MD Anderson Experience with hospitalized COVID-19-positive patients. Support Care Cancer 31(12):661, 2023. e-Pub 2023. PMID: 37906311.
      5. Muthu M, Dalal S, George M, Clavijo CS, Lenz C, Nortje N. The Importance of Facilitating Goal-Concordant Care (GCC) in a Pandemic: The MD Anderson Experience with hospitalized COVID-19 positive patients. Res Sq, 2023. e-Pub 2023. PMID: 37398052.
      6. Reddy A, Haider A, Arthur J, Hui D, Dalal S, Dev R, Tanco K, Amaram-Davila J, Hernandez F, Chavez P, De Moraes AR, Wu J, Nguyen K, Subbiah I, Epner D, Shelal Z, Guay MOD, Mallipeddi T, Bruera E. Levorphanol as a Second Line Opioid in Cancer Patients Presenting to an Outpatient Supportive Care Center: An Open-label Study. J Pain Symptom Manage 65(6):e683-e690, 2023. e-Pub 2023. PMID: 36720398.
      7. Hui D, Nortje N, George M, Wilson K, Urbauer DL, Lenz CA, Wallace SK, Andersen CR, Mendoza T, Haque S, Ahmed S, Delgado-Guay M, Dalal S, Rathi N, Reddy A, McQuade J, Flowers C, Pisters P, Aloia T, Bruera E. Impact of an Interdisciplinary Goals-of-Care Program Among Medical Inpatients at a Comprehensive Cancer Center During the COVID-19 Pandemic: A Propensity Score Analysis. J Clin Oncol 41(3):JCO2200849, 2023. e-Pub 2022. PMID: 36201711.
      8. Reddy A, Sinclair C, Crawford GB, McPherson ML, Mercadante S, Hui D, Haider A, Arthur J, Tanco K, Dalal S, Dev R, Amaram-Davila J, Adile C, Liu D, Schuler U, Jammi S, Shelal Z, Del Fabbro E, Davis M, Bruera E. Opioid Rotation and Conversion Ratios Used by Palliative Care Professionals: An International Survey. J Palliat Med 25(10):1557-1562, 2022. e-Pub 2022. PMID: 35930252.
      9. Dev R, Zhong LL, Zarifa A, Albittar AA, Rubin L, Liu S, Yap TA, Dalal S, Hui D, Karp DD, Tsimberidou AM, Piha-Paul SA, Ahnert JR, Fu S, Meric-Bernstam F, Naing A. Supportive care for the prevention of nausea, vomiting and anorexia in a phase 1B study of selinexor in advanced cancer patients: an exploratory study. Invest New Drugs 40(1):124-133, 2022. e-Pub 2022. PMID: 34559346.
      10. Reddy A, Arthur J, Dalal S, Hui D, Subbiah I, Wu J, Anderson AE, Castro D, Joy M, Nweke C, Gogineni M, Maddi R, de Moraes AR, Shelal Z, Bruera E. Rapid Transition to Virtual Care during the COVID-19 Epidemic: Experience of a Supportive Care Clinic at a Tertiary Care Cancer Center. J Palliat Med 24(10):1467-1473, 2021. e-Pub 2021. PMID: 33535019.
      11. Dans M, Kutner JS, Agarwal R, Baker JN, Bauman JR, Beck AC, Campbell TC, Carey EC, Case AA, Dalal S, Doberman DJ, Epstein AS, Fecher L, Jones J, Kapo J, Lee RT, Loggers ET, McCammon S, Mitchell W, Ogunseitan AB, Portman DG, Ramchandran K, Sutton L, Temel J, Teply ML, Terauchi SY, Thomas J, Walling AM, Zachariah F, Bergman MA, Ogba N, Campbell M. NCCN Guidelines® Insights: Palliative Care, Version 2.2021. J Natl Compr Canc Netw 19(7):780-788, 2021. e-Pub 2021. PMID: 34340208.
      12. Arthur JA, Tang M, Lu Z, Hui D, Nguyen K, Rodriguez EM, Edwards T, Yennurajalingam S, Dalal S, Dev R, Reddy A, Tanco K, Haider A, Liu DD, Bruera E. Random urine drug testing among patients receiving opioid therapy for cancer pain. Cancer 127(6):968-975, 2021. e-Pub 2021. PMID: 33231885.
      13. Reddy A, Vidal M, Haider A, Arthur J, Hui D, Wu J, Liu D, Holmes C, Carrol M, Dalal S, Dev R, Tanco K, Bruera E. A retrospective review of the use of oxymorphone immediate release for long term pain control in cancer patients with gastrostomy tubes. Ann Palliat Med 10(3):2662-2667, 2021. e-Pub 2021. PMID: 33549000.
      14. Hui D, De La Rosa A, Wilson A, Nguyen T, Wu J, Delgado-Guay M, Azhar A, Arthur J, Epner D, Haider A, De La Cruz M, Heung Y, Tanco K, Dalal S, Reddy A, Williams J, Amin S, Armstrong TS, Breitbart W, Bruera E. Neuroleptic strategies for terminal agitation in patients with cancer and delirium at an acute palliative care unit: a single-centre, double-blind, parallel-group, randomised trial. Lancet Oncol 21(7):989-998, 2020. e-Pub 2020. PMID: 32479786.
      15. Hui D, Abdelghani E, Chen J, Dibaj S, Zhukovsky D, Dev R, Tanco K, Haider A, Azhar A, Reddy A, Epner D, Arthur J, Dalal S, Heung Y, Reddy S, De La Cruz M, Liu D, Bruera E. Chronic Non-Malignant Pain in Patients with Cancer Seen at a Timely Outpatient Palliative Care Clinic. Cancers (Basel) 12(1), 2020. e-Pub 2020. PMID: 31952220.
      16. Haider A, Azhar A, Nguyen K, Dev R, Naqvi SMA, Naqvi SMA, Edwards T, Reddy A, Dalal S, Tanco KC, Arthur J, Williams JL, Park M, Liu DD, Dibaj SS, Bruera E. Concurrent use of opioids with benzodiazepines or nonbenzodiazepine sedatives among patients with cancer referred to an outpatient palliative care clinic. Cancer 125(24):4525-4531, 2019. e-Pub 2019. PMID: 31460669.
      17. Dev R, Del Fabbro E, Dalal S. Endocrinopathies and cancer cachexia. Curr Opin Support Palliat Care 13(4):286-291, 2019. e-Pub 2019. PMID: 31567482.
      18. Hui D, Hernandez F, Larsson L, Liu D, Kilgore K, Naberhuis J, Virgilio A, Reddy S, Reddy A, Dalal S, Haider A, Driver L, Azhar A, Dev R, Bruera E. Prophylactic Fentanyl Sublingual Spray for Episodic Exertional Dyspnea in Cancer Patients: A Pilot Double-Blind Randomized Controlled Trial. J Pain Symptom Manage 58(4):605-613, 2019. e-Pub 2019. PMID: 31276809.
      19. Haider A, Qian Y, Lu Z, Naqvi S, Zhuang A, Reddy A, Dalal S, Arthur J, Tanco K, Dev R, Williams J, Wu J, Liu D, Bruera E. Implications of the Parenteral Opioid Shortage for Prescription Patterns and Pain Control Among Hospitalized Patients With Cancer Referred to Palliative Care. JAMA Oncol 5(6):841-846, 2019. e-Pub 2019. PMID: 30896771.
      20. Arthur J, Tanco K, Park M, Haider A, Maligi C, Dalal S, Naqvi SMA, Liu D, Bruera E. Personalized Pain Goal as an Outcome Measure in Routine Cancer Pain Assessment. J Pain Symptom Manage 56(1):80-87, 2018. e-Pub 2018. PMID: 29526610.
      21. Hui D, Hess K, Dibaj SS, Arthur J, Dev R, Dalal S, Reddy S, Bruera E. The minimal clinically important difference of the Richmond Agitation-Sedation Scale in patients with cancer with agitated delirium. Cancer 124(10):2246-2252, 2018. e-Pub 2018. PMID: 29469951.
      22. Dalal S, Moore JA, Gallagher CM. We Didn't Consent to This. Narrative Inquiry in Bioethics 7(2):171-178, 2017. e-Pub 2017. PMID: 29056648.
      23. Dans M, Smith T, Back A, Baker JN, Bauman JR, Beck AC, Block S, Campbell T, Case AA, Dalal S, Edwards H, Fitch TR, Kapo J, Kutner JS, Kvale E, Miller C, Misra S, Mitchell W, Portman DG, Spiegel D, Sutton L, Szmuilowicz E, Temel J, Tickoo R, Urba SG, Weinstein E, Zachariah F, Bergman MA, Scavone JL. NCCN Guidelines Insights: Palliative Care, Version 2.2017. J Natl Compr Canc Netw 15(8):989-997, 2017. e-Pub 2017. PMID: 28784860.
      24. Levy M, Smith T, Alvarez-Perez A, Back A, Baker JN, Beck AC, Block S, Dalal S, Dans M, Fitch TR, Kapo J, Kutner JS, Kvale E, Misra S, Mitchell W, Portman DG, Sauer TM, Spiegel D, Sutton L, Szmuilowicz E, Taylor RM, Temel J, Tickoo R, Urba SG, Weinstein E, Zachariah F, Bergman MA, Scavone JL. Palliative Care Version 1.2016. J Natl Compr Canc Netw 14(1):82-113, 2016. e-Pub 2016. PMID: 26733557.
      25. Dalal S, Bruera S, Hui D, Yennu S, Dev R, Williams J, Masoni C, Ihenacho I, Obasi E, Bruera E. Use of Palliative Care Services in a Tertiary Cancer Center. Oncologist 21(1):110-8, 2016. e-Pub 2016. PMID: 26614711.
      26. Dalal S, Hui D, Dev R, Yeung S, Sobti N, de la Cruz M, Vidal M, Bedi D, Bruera E, Litton J. Prognostic Role of Skeletal Muscle Mass and Fat Distribution on Clinical Outcomes in Post-menopausal Women with Operable Stage Breast Cancer. Journal of Cachexia, Sarcopenia and Muscle, 2015. e-Pub 2015.
      27. Hui D, Park M, Liu D, Reddy A, Dalal S, Bruera E. Attitudes and Beliefs Toward Supportive and Palliative Care Referral Among Hematologic and Solid Tumor Oncology Specialists. Oncologist 20(11):1326-32, 2015. e-Pub 2015. PMID: 26417037.
      28. Hui D, dos Santos R, Reddy S, Nascimento MS, Zhukovsky DS, Paiva CE, Dalal S, Costa ED, Walker P, Scapulatempo HH, Dev R, Crovador CS, De La Cruz M, Bruera E. Acute symptomatic complications among patients with advanced cancer admitted to acute palliative care units: A prospective observational study. Palliat Med 29(9):826-33, 2015. e-Pub 2015. PMID: 25881622.
      29. Naing A, Dalal S, Abdelrahim M, Wheler J, Hess K, Fu S, Hong DS, Janku F, Falchook GS, Ilustre A, Ouyang F, Kurzrock R. Olanzapine for cachexia in patients with advanced cancer: an exploratory study of effects on weight and metabolic cytokines. Support Care Cancer 23(9), 2015. e-Pub 2015. PMID: 25680763.
      30. Dev R, Hui D, Del Fabbro E, Delgado-Guay MO, Sobti N, Dalal S, Bruera E. Association between hypogonadism, symptom burden, and survival in male patients with advanced cancer. Cancer 120(10), 2015. e-Pub 2015. PMID: 24577665.
      31. Dev R, Hui D, Chisholm G, Delgado-Guay M, Dalal S, Del Fabbro E, Bruera E. Hypermetabolism and symptom burden in advanced cancer patients evaluated in a cachexia clinic. J Cachexia Sarcopenia Muscle 6(1):95-8, 2015. e-Pub 2015. PMID: 26136416.
      32. Wu W, Liu X, Chaftari P, Cruz Carreras MT, Gonzalez C, Viets-Upchurch J, Merriman K, Tu SM, Dalal S, Yeung SC. Association of body composition with outcome of docetaxel chemotherapy in metastatic prostate cancer: a retrospective review. PLoS One 10(3):e0122047, 2015. e-Pub 2015. PMID: 25822612.
      33. Reddy A, Yennurajalingam S, Desai H, Reddy S, de la Cruz M, Wu J, Liu D, Rodriguez EM, Waletich J, Shin SH, Gayle V, Patel P, Dalal S, Vidal M, Tanco K, Arthur J, Tallie K, Williams J, Silvestre J, Bruera E. The opioid rotation ratio of hydrocodone to strong opioids in cancer patients. Oncologist 19(11):1186-93, 2014. e-Pub 2014. PMID: 25342316.
      34. Levy MH, Smith T, Alvarez-Perez A, Back A, Baker JN, Block S, Codada SN, Dalal S, Dans M, Kutner JS, Kvale E, Misra S, Mitchell W, Sauer TM, Spiegel D, Sutton L, Taylor RM, Temel J, Tickoo R, Urba SG, Van Zyl C, Weinstein SM, Bergman MA, Scavone JL. Palliative care, version 1.2014. J Natl Compr Canc Netw 12(10):1379-88, 2014. e-Pub 2014. PMID: 25313178.
      35. Dev R, Hui D, Del Fabbro E, Delgado-Guay MO, Sobti N, Dalal S, Bruera E. Association between hypogonadism, symptom burden, and survival in male patients with advanced cancer. Cancer 120(10):1586-93, 2014. e-Pub 2014. PMID: 24577665.
      36. Rhondali W, Burt S, Wittenberg-Lyles E, Bruera E, Dalal S. Medical oncologists' perception of palliative care programs and the impact of name change to supportive care on communication with patients during the referral process. A qualitative study. Palliat Support Care 11(5):1-8, 2013. e-Pub 2013. PMID: 23302500.
      37. Yennurajalingam S, Frisbee-Hume S, Palmer JL, Delgado-Guay MO, Bull J, Phan AT, Tannir NM, Litton JK, Reddy A, Hui D, Dalal S, Massie L, Reddy SK, Bruera E. Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer. J Clin Oncol 31(25):3076-82, 2013. e-Pub 2013. PMID: 23897970.
      38. Dalal S, Tanco KC, Bruera E. State of art of managing pain in patients with cancer. Cancer J 19(5):379-89, 2013. e-Pub 2013. PMID: 24051610.
      39. Rhondali W, Perez-Cruz P, Hui D, Chisholm GB, Dalal S, Baile W, Chittenden E, Bruera E. Patient-physician communication about code status preferences: A randomized controlled trial. Cancer 119(11):2067-73, 2013. e-Pub 2013. PMID: 23564395.
      40. S Dalal S, E Bruera E. Access to Opioid Analgesics and Pain Relief for Patients With Cancer. Nature Reviews Clinical Oncology 10(2):108-116, 2013. e-Pub 2013.
      41. Bruera E, Hui D, Dalal S, Torres-Vigil I, Trumble J, Roosth J, Krauter S, Strickland C, Unger K, Palmer JL, Allo J, Frisbee-Hume S, Tarleton K. Parenteral hydration in patients with advanced cancer: a multicenter, double-blind, placebo-controlled randomized trial. J Clin Oncol 31(1):111-8, 2013. e-Pub 2013. PMID: 23169523.
      42. Levy MH, Adolph MD, Back A, Block S, Codada SN, Dalal S, Deshields TL, Dexter E, Dy SM, Knight SJ, Misra S, Ritchie CS, Sauer TM, Smith T, Spiegel D, Sutton L, Taylor RM, Temel J, Thomas J, Tickoo R, Urba SG, Von Roenn JH, Weems JL, Weinstein SM, Freedman-Cass DA, Bergman MA, Cancer Network) N(C. Palliative care. J Natl Compr Canc Netw 10(10):1284-309, 2012. e-Pub 2012. PMID: 23054879.
      43. Dev R, Dalal S, Bruera E. Is there a role for parenteral nutrition or hydration at the end of life?. Curr Opin Support Palliat Care 6(3):365-370, 2012. e-Pub 2012. PMID: 22801468.
      44. Dalal S, Hui D, Nguyen L, Chacko R, Scott C, Roberts L, Bruera E. Achievement of personalized pain goal in cancer patients referred to a supportive care clinic at a comprehensive cancer center. Cancer 118(15):3869-77, 2012. e-Pub 2012. PMID: 22180337.
      45. Dalal S, Hui D, Bidaut L, Lem K, Del Fabbro E, Crane C, Reyes-Gibby CC, Bedi D, Bruera E. Relationships among body mass index, longitudinal body composition alterations, and survival in patients with locally advanced pancreatic cancer receiving chemoradiation: a pilot study. J Pain Symptom Manage 44(2):181-91, 2012. e-Pub 2012. PMID: 22695045.
      46. Hui D, Arthur J, Dalal S, Bruera E. Quality of the supportive and palliative oncology literature: a focused analysis on randomized controlled trials. Support Care Cancer 20(8):1779-1785, 2012. e-Pub 2012. PMID: 21935717.
      47. Hui D, Kilgore K, Fellman B, Urbauer D, Hall S, etal. Development and Cross-Validation of the In-Hospital Mortality Prediction in Advanced Cancer Patients Score: A Preliminary Study. Journal of Palliative Medicine 15(8):902-09, 2012. e-Pub 2012.
      48. Hui D, Kilgore K, Nguyen L, Hall S, Fajardo J, Cox-Miller TP, Palla SL, Rhondali W, Kang JH, Kim SH, Del Fabbro E, Zhukovsky DS, Reddy S, Elsayem A, Dalal S, Dev R, Walker P, Yennu S, Reddy A, Bruera E. The Accuracy of Probabilistic Versus Temporal Clinician Prediction of Survival for Patients with Advanced Cancer: A Preliminary Report. Oncologist, 2011. e-Pub 2011. PMID: 21976316.
      49. Del Fabbro E, Nooruddin Z, Hui D, Dalal S, Bruera E. Nutrition Impact Symptoms in Cancer Patients Referred to a Cachexia Clinic at a Comprehensive Cancer Center. J Palliat Med 14(9):1004-1008, 2011. e-Pub 2011. PMID: 21793729.
      50. Del Fabbro E, Hui D, Dalal S, Dev R, Noorhuddin Z, Bruera E. Clinical Outcomes and Contributors to Weight Loss in a Cancer Cachexia Clinic. J Palliat Med 14(9):1004-8, 2011. e-Pub 2011. PMID: 21793729.
      51. Dev R, Hui D, Dalal S, Nooruddin ZI, Yennurajalingam S, Del Fabbro E, Bruera E. Association between serum cortisol and testosterone levels, opioid therapy, and symptom distress in patients with advanced cancer. J Pain Symptom Manage 41(4):788-95, 2011. e-Pub 2011. PMID: 21276699.
      52. Del Fabbro E, Dev R, Hui D, Dalal S, Bruera E. Secondary Cachexia in Patients with Advanced Cancer. J Pain Symptom Manage 41(1):233-234, 2011. e-Pub 2011.
      53. Dalal S, Palla S, Hui D, Nguyen L, Chacko R, Li Z, Fadul N, Scott C, Thornton V, Coldman B, Amin Y, Bruera E. Association Between a Name Change from Palliative to Supportive Care and the Timing of Patient Referrals at a Comprehensive Cancer Center. Oncologist 16(1):105-111, 2011. e-Pub 2011. PMID: 21212438.
      54. Del Fabbro E, Hui D, Nooruddin Z, Dalal S, Dev R, Freer G, Palmer JL, Bruera E. Association between hypogonadism, inflammatory marker, symptom survival in cancer patients with cachexia: A preliminary report. Cancer, 2010. e-Pub 2010.
      55. Del Fabbro E, Hui D, Nooruddin ZI, Dalal S, Dev R, Freer G, Roberts L, Palmer JL, Bruera E. Associations Among Hypogonadism, C-Reactive Protein, Symptom Burden, and Survival in Male Cancer Patients with Cachexia: A Preliminary Report. J Pain Symptom Manage 39(6):1016-1024, 2010. e-Pub 2010. PMID: 20457506.
      56. Mori M, Fadul NA, Bruera E, Dalal S. Hypocalcemia Associated with Strontium-89 Administration in a Patient with Diffuse Bone Metastases from Neuroendocrine Carcinoma. J Pain Symptom Manage 37(5):923-929, 2009. e-Pub 2009. PMID: 19041217.
      57. Fadul NA, El Osta B, Dalal S, Poulter VA, Bruera E. Comparison of Symptom Burden among Patients Referred to Palliative Care with Hematologic Malignancies versus those with Solid Tumors. J Palliat Med 11(3):422-7, 2008. e-Pub 2008. PMID: 18363482.
      58. Dalal S, Del Fabbro E, Bruera E. Symptom control in palliative care-part I: oncology as a paradigmatic example. J Palliat Med 9(2):391-408, 2006. e-Pub 2006. PMID: 16629570.
      59. Del Fabbro E, Dalal S, Bruera E. Symptom Control in Palliative Care-Part II: Cachexia/Anorexia and Fatigue. J Palliat Med 9(2):409-21, 2006. e-Pub 2006. PMID: 16629571.
      60. Del Fabbro E, Dalal S, Bruera E. Symptom Control in Palliative Care-Part III: Dyspnea and Delirium. J Palliat Med 9(2):422-36, 2006. e-Pub 2006. PMID: 16629572.
      61. Dalal, S. The impact of race/ethnicity on the prognostic associations between general and visceral obesity and breast cancer outcomes. Society on Sarcopenia, Cachexia and Wasting Disorders (SCWD).
      62. Dalal S. Lipid Metabolism in Cancer Cachexia. Ann Palliative Med 2018. PMID: 30525767.
      63. Dalal S. Intravenous Naloxone Utilization among hospitalized cancer patients on Opioids at a Tertiary Cancer Center. MASCC/ISOO 2018 Annual Meeting.

      Invited Articles

      1. Dalal S, Bruera E. Pain Management for Patients With Advanced Cancer in the Opioid Epidemic Era. Am Soc Clin Oncol Educ Book 39:24-35, 2019. e-Pub 2019. PMID: 31099619.
      2. Dev R, Bruera E, Dalal S. Insulin Resistance and Body Composition in Cancer Patients. Ann Oncol 29(suppl_2):ii18-ii26, 2018. e-Pub 2018. PMID: 29506229.
      3. Dalal S, Bruera E. Assessing cancer pain. Curr Pain Headache Rep 16(4):314-24, 2012. e-Pub 2012. PMID: 22585314.
      4. Dalal S. Book Review: Ensuring Delivery of the Highest Quality of Care for Dying Patients. J Pain Symptom Manage 42(6):967-968, 2011. e-Pub 2011.
      5. Dalal S, Bruera E. Assessment and management of pain in the terminally ill. Prim Care Clinic Office Pract 38(2):195-223, 2011. e-Pub 2011. PMID: 21628035.
      6. Dalal S, Bruera E. Global Perspectives in Cancer Pain--progress and ongoing issues in the United States. Pain Res Manag 14(5):363-364, 2009. e-Pub 2009. PMID: 19946974.
      7. Rapoport BL, Aapro M, Klastersky J, Saunders D, Dalal S. How Adherence to Guidelines Increases Cost-Effectiveness of Support Care Interventions. Supportive Care in Cancer.

      Review Articles

      1. Reddy A, González JB, Rizvi A, Nortje N, Dalal S, Haider A, Amaram-Davila JS, Bramati P, Chen M, Hui D, Bruera E. Impact of an Institution-Wide Goals of Care Program on the Timing of Referrals to Outpatient Palliative Care. J Pain Symptom Manage 66(6):e666-e671, 2023. e-Pub 2023. PMID: 37643654.
      2. Coveler AL, Mizrahi J, Eastman B, Apisarnthanarax SJ, Dalal S, McNearney T, Pant S, Consortium PP. Pancreas Cancer-Associated Pain Management. Oncologist 26(6):e971-e982, 2021. e-Pub 2021. PMID: 33885205.
      3. Liu W, Lopez G, Narayanan S, Qdaisat A, Geng Y, Zhou S, Spano M, Underwood S, Eclache MG, Dev R, Dalal S, Bruera E, Cohen L. Acupuncture for Cancer-Related Anorexia: a Review of the Current Evidence. Curr Oncol Rep 23(7):82, 2021. e-Pub 2021. PMID: 33948746.
      4. Dalal S, Bruera E. End of Life Care Matters: Palliative Cancer Care Results in Better Care and Lower Costs. Oncologist 22(4):361-368, 2017. e-Pub 2017. PMID: 28314840.
      5. Dalal S, Del Fabbro E, Bruera E. Is there a role for hydration at the end of life?. Curr Opin Support Palliat Care 3(1):72-78, 2009. e-Pub 2009. PMID: 19365165.
      6. Dalal S, Zhukovsky DS. Pathophysiology and management of hot flashes. J Support Oncol 4(7):315-20, 325, 2006. e-Pub 2006. PMID: 16892692.
      7. Dalal S, Zhukovsky DS. Pathophysiology and management of fever. J Support Oncol 4(1):9-16, 2006. e-Pub 2006. PMID: 16444847.
      8. Dalal S, Bruera E. Dehydration in cancer patients: to treat or not to treat. J Support Oncol 2(6):467-79, 483, 2004. e-Pub 2004. PMID: 15605914.

      Professional Educational Materials

      1. Dalal S. Cachexia: M.D. Anderson's Guide to Palliative Care for Nurses, 2006.
      2. Dalal S. Fatigue: M.D. Anderson's Guide to Palliative Care for Nurses, 2006.

      Other Articles

      1. Dalal S Management of pain in the cancer patient. Frontiers in Pain Research, section Cancer Pain, 2022.
      2. Dalal, S, Bruera, E Management of pain in the cancer patient. Frontiers in Pain Research 3, 2022. PMID: 36003830.
      3. Dalal S Upto Date: Palliative Care: Review of Overview of pruritus and sweating in palliative care, 2020.
      4. Dalal S, Bruera E UpToDate: Palliative care: Overview of pruritus and sweating.

      Abstracts

      1. Dalal S, Hui D, Nguyen LMT, Chacko R, Bruera E. Assessment of personalized pain goal (PPG) in cancer patients referred to a supportive-care clinic at a comprehensive cancer center. Palliative Medicine 26(4)(563):P250, 2016. e-Pub 2016.
      2. Dalal S, DevR, TancoK, WilliamsJ, BrueraE. Predictors of Early Referral of Advanced Cancer Patients to an Outpatient Palliative Care Specialty Clinic in a Tertiary Cancer Hospital. Palliative Care in Oncology Symposium. e-Pub 2015.
      3. Hui D, Dos Santos R, Reddy S, Nascimento MS, Zhukovsky DS, Paiva CE, Dalal S, Costa ED, Walker P, Scapulatempo HH, Dev R, Crovador CS, De La Cruz M, Bruera E. Acute symptomatic complications among patients with advanced cancer admitted to acute palliative care units: A prospective observational study. Palliat Med, 2015. e-Pub 2015. PMID: 25881622.
      4. Dev R, Hui D, Chisholm G, Delgado-Guay M, Dalal S, Del Fabbro E, Bruera E. Hypermetabolism and symptom burden in advanced cancer patients evaluated in a cachexia clinic. J Cachexia Sarcopenia Muscle 6(1):95-8, 2015. e-Pub 2015. PMID: 26136416.
      5. Hui D, Park M, Liu D, Reddy A, Dalal S, Bruera E. Attitudes and Beliefs toward Supportive Care Referral among Hematologic and Solid Tumor Oncology Specialists. Support Care in Cancer 23(S1)(S352):26-016-P, 2015. e-Pub 2015. PMID: 26041765.
      6. Dalal S, Bruera S, Hui D, Yennu S, Williams J, Masino C, Ilhenacho I, Zhang YI, Obasi E, Schuren N, Bruera E. Integration of Palliative Care Services with Oncology Practice: What's in a Name?. Supportive Care in Cancer 23(S1)(S219):17-47P, 2015. e-Pub 2015.
      7. Dalal S, Yeung S, Hui D, Ihenacho I, Ogunti R, de la Cruz M, Vidal M, Dev R, Bedi D, Bruera E, Litton J. Association between abdominal fat distribution and clinical outcomes in postmenopausal women with operable stage breast cancer. Supportive Care in Cancer 22(suppl_1), 2014. e-Pub 2014.
      8. Dalal S, Hui D, Yeung SJ, Chisholm GB, Ilhenacho IS, Ogunti R, de la Cruz V, Vidal M, Bedi D, Dev R, Bruera E, Litton JK. Association between visceral adiposity, BMI, and clinical outcomes in postmenopausal women with operable breast cancer. Journal of Clinical Oncology 32(15S)(513), 2014. e-Pub 2014.
      9. Dalal S, Hui D, Yeung S, Chisholm G, Ihenacho I, Ogunti R, de La Cruz M, Vidal M, Bedi D, Dev R, Bruera E, Litton J. Association between visceral adiposity, BMI, and clinical outcomes in postmenopausal women with operable breast cancer. J Clin Oncol 32(suppl - abstract 513):5s, 2014. e-Pub 2014.
      10. Dalal S, Bruera S, Masino C, Williams J, Zhang Y, Obasi E, Schuren N, Bruera E. Timing of access to outpatient palliative care services: What’s in a name?. J Clin Oncol 32(suppl_31 - abstract 10), 2014. e-Pub 2014.
      11. Dalal S, Pimentel LE, Wygant C. Multidimensional Assessment Of Cancer Pain. Moving Beyond The Basics. 2013 American Academy of Hospice and Palliative Medicine & Hospice and Palliative Nurses Association Annual Assembly, 2013. e-Pub 2013.
      12. Dalal S, Hui D, Nguyen LMT, Chacko R, Bruera E. Achievement of personalized pain goal (PPG) in cancer patients referred to a supportive-care clinic. Journal of Clinical Oncology 29(9060), 2012. e-Pub 2012.
      13. Dalal S, Hui D, Torres-Vigil I, Allo J, Frisbee-Hume S, Tarleton K, Bruera E. 1.Parenteral hydration (PH) in advanced cancer patients: A multi-center, double-blind, placebo-controlled randomized trial. Journal of Clinical Oncology, 2012. e-Pub 2012.
      14. Rhondali W, Perez-Cruz PE, Hui D, Chisholm GB, Dalal S, Baile WB, Chittenden E, Filbet M, Bruera E. Patient-Physician communication about code status preferences: A randomized controlled trial. Journal of Clinical Oncology, 2012. e-Pub 2012.
      15. Yennurajalingam S, Frisbee-Hume S, Delgado-Guay MO, Bull J, Phan AT, Tannir NM, Litton JK, Palmer JL, Reddy AS, Hui D, Dalal S, Massie L, Vadhan-Raj S, Reddy SK, Reuben JM, Bruera E. Dexamethasone (DM) for cancer-related fatigue: A double-blinded, randomized, placebo-controlled trial. Journal of Clinical Oncology, 2012. e-Pub 2012.
      16. Perez-Cruz PE, Hui D, Rd S, Kilgore KL, Silva TB, Chisholm GB, Leite A, Crovador CS, Fabbro ED, Nascimento MS, Zhukovsky DS, Lourdes FD, Reddy SK, Frascari LM, Dalal S, Paiva CE, Dev R, Hall S, Fajardo J, Bruera E. Temporal versus probabilistic approach to survival estimation: Physician’s accuracy over time. Journal of Clinical Oncology, 2012. e-Pub 2012.
      17. Dalal S, Hui D, Torres-Vigil I, Palmer JL, Allo J, Frisbee-Hume S, Tarleton K, Bruera E. Parenteral hydration (PH) in advanced cancer patients: A multi-center, double-blind, placebo-controlled randomized trial. 2012 Proceedings of American Society Clinical Oncology (ASCO), Annual Meeting. e-Pub 2012.
      18. Dalal S, Hui D, Nguyen L, Chacko R, Bruera E. Assessment of personalized pain goal (PPG) in cancer patients referred to the Supportive Care Clinic for pain management. 7th World Research Congress of the European Association for Palliative Care, 2012. e-Pub 2012.
      19. Hui D, Kilgore KL, Nguyen LMT, Hall S, Fajardo J, Cox-Miller T, Urbauer D Fellman B, Rhondali W, Kang JH, Kim H, Del Fabbro E, Zhukovsky DS, Reddy SK, Elsayem AF, Dalal S, Walker P, Dev R, Yennurajalingam S, Bruera E. Predictors of in-hospital mortality in advanced cancer patients submitted to an acute palliative care unit (APCU): A prospective study Proceedings of Multinational Association of Supportive Care in Cancer (MASCC), Annual Meeting. Support Care Cancer 19(Supplement 2):S221, 2011. e-Pub 2011. PMID: 21656340.
      20. Dalal S, Hui D, Ngyuen L, Chacko R, Bruera. Achievement of personalized pain goal (PPG) in cancer patients referred to the supportive care clinic at a comprehensive cancer center. Proceedings of Multinational Association of Supportive Care in Cancer (MASCC), Annual Meeting. Journal of Supportive Care in Cancer 19(Suppl 2), 2011. e-Pub 2011.
      21. Hui D, Kilgore K, Nguyen L, Hall S, Fajardo J, Cox-Miller T, Rhondali W, Kim SH, Kang, JH, Palla S, Del Fabbro E, Zhukovsky DS, Reddy S Elsayem A, Dalal S, Walker P, Dev R, Yennu S, Reddy A, Bruera E. The accuracy of clinical prediction of survival (CPS) for advanced cancer patients: The role of profession and probability questionProceedings of Multinational Association of Supportive Care in Cancer (MASCC), Annual Meeting. Journal of Supportive Care in Cancer 19(Suppl 2), 2011. e-Pub 2011.
      22. Dev R, Del Fabbro E, Palla S, Hui D, Guitierrez N, Dalal S, Yennurajalingam S Bruera E. Vitamin D Deficiency and Endogrin Abnormalities in Advanced Cancer Patients Proceedings of Multinational Association of Supportive Care in Cancer (MASCC), Annual Meeting. Journal of Supportive Care in Cancer 19(Suppl 2), 2011. e-Pub 2011.
      23. Dalal S, Hui D, Nguyen LMT, Chacko R, Bruera E. Achievement of personalized pain goal (PPG) in cancer patients referred to a supportive care clinic. Proceedings of American Association of Clinical Oncology, Annual Meeting. Journal of Clinical Oncology 29(15S), 2011. e-Pub 2011.
      24. Dalal S, Palla SL, Chacko R, Nguyen L, Fadul N, Li Z, Bruera E. Impact of change in service name from "Palliative" to "Supportive" care on patient referral at a comprehensive cancer center. Proceedings of American Society of Clinical Oncology (ASC0), Annual Meeting. Journal of Clinical Oncology 28(15S), 2010. e-Pub 2010.
      25. Dalal S, Palla S, Chacko R, Nguyen L, Fadul N, Bruera E. Does A Name Change from "Palliative" to "Supportive" Care Have Any Impact on Patient Referrals? A Retrospective Data Review. Proceedings of Multinational Association of Supportive Care in Cancer (MASCC), Annual Meeting. Journal of Supportive Care in Cancer 18(Supplement 3):S67-S220, 2010. e-Pub 2010.
      26. Del Fabbro D, Dalal S, Bruera E. A randomized placebo-controlled trial of melatonin for poor appetite in advanced cancer patients. Proceedings of American Association of Clinical Oncology, Annual Meeting. Journal of Clinical Oncology 28(15S), 2010. e-Pub 2010.
      27. Dalal S, Hui D, Noorruddin Z, Del Fabbro E, Freer G, Bruera E. Impact of a Multidisciplinary Cachexia Clinic at a Tertiary Cancer Hospital on Patient Related Outcomes. Proceedings of Multinational Association in Supportive Care (MASCC), Annual Meeting. Journal of Supportive Care in Cancer 17, 2009. e-Pub 2009.
      28. Nooruddin Z, Hui D, Dalal S, Bruera E, Del Fabbro E. Findings and Interventions in Cancer Patients referred to a Cachexia Clinic. Proceedings of Multinational Association in Supportive Care (MASCC), Annual Meeting. Journal of Supportive Care in Cancer 17, 2009. e-Pub 2009.
      29. Del Fabbro E, Hui D, Nooruddin Z, Dalal S, Palmer L, Bruera E. Association Between Inflammatory Markers, Symptom Burden, Hypogonadism and Survival In Cancer Patients with Cachexia. Proceedings of Multinational Association of Supportive Care in Cancer (MASCC), Annual Meeting. Journal of Supportive Care in Cancer 17:857-1039, 2009. e-Pub 2009.
      30. Del Fabbro E, Hui D, Nooruddin ZR, Dalal S, Dev R, Freer G, Palmer L, Bruera E. Association between inflammatory markers, symptom burden, hypogonadism and survival in cancer patients with cachexia. Proceedings of American Society Clinical Oncology (ASCO), Annual Meeting. Journal of Clinical Oncology 27(15S), 2009. e-Pub 2009.
      31. Braiteh F, Dalal S, Khuwaja A, David H, Bruera E, Kuzrock R. Phase I pilot study of the safety and tolerability of olanzapine (OZA) for the treatment of cachexia in patients with advanced cancer. Proceedings of American Society Clinical Oncology (ASCO), Annual Meeting. Journal of Clinical Oncology 26(I5S), 2008. e-Pub 2008.
      32. Dalal S, Del Fabbro E, Freer G, Bruera E. Relationship between inflammation and symptom distress in cachectic cancer patients assessed at a cachexia clinic in a comprehensive cancer center. Proceedings of Multinational Association in Supportive Care (MASCC), Annual Meeting. Journal of Supportive Care in Cancer 16, 2008. e-Pub 2008.
      33. Dalal S, Hui D, Bidaut L, Hess K, Crane C, Bruera E. Gender based differences in the relationship between body composition alterations, as measured by computerized tomography (CT) imaging, and survival, in locally advanced pancreatic cancer (LAPC) receiving chemoradiation. Proceedings of Multinational Association of Supportive Care in Cancer (MASCC), Annual Meeting. Journal of Supportive Care in Cancer 16, 2008. e-Pub 2008.
      34. Dalal S, Hui D, Bidaut L, Del Fabbro E, Reyes-Gibby C, Deepak B, Lem K, Hess K, Crane C, Bruera E. Differential Impact of Changes in Muscle and Adipose Tissue on Survival of Men and Women with Locally Advanced Pancreatic Cancer (LAPC) receiving Chemoradiation (CRT). Proceedings of American Society Clinical Oncology (ASCO), Annual Meeting. Journal of Clinical Oncology 26(May 20 suppl), 2008. e-Pub 2008.
      35. Fadul N, El Osta B, Dalal S, Elsayem A, Bruera E. Symptom burden severity in patients with advanced solid vs. hematological malignancies. Proceedings of Multinational Association in Supportive Care (MASCC), Annual Meeting. Journal of Supportive Care in Cancer 15, 2007. e-Pub 2007.
      36. Reddy S, Dalal S, Swafford J, El Osta B, Pei B, Palmer J, Bruera E. The effect of methadone on the QTc interval in advanced cancer patients. Proceedings of American Society Clinical Oncology (ASCO), Annual Meeting. Journal of Clinical Oncology 25(18S), 2007. e-Pub 2007.
      37. Dalal S, Del Fabbro E, Yennurajalingam S, Palmer S, Bruera E. Cachexia syndrome symptom cluster in patients referred to a specialized cachexia clinic in a comprehensive cancer center. Proceedings of Multinational Association in Supportive Care (MASCC), Annual Meeting. Journal of Supportive Care in Cancer 15:774-775, 2007. e-Pub 2007.
      38. Del Fabbro E, Dalal S, Delgado M, Freer G, Bruera E. Secondary vs. primary cachexia in patients with advanced cancer. Proceedings of American Society Clinical Oncology (ASCO) Annual Meeting. Journal of Clinical Oncology. Journal of Clinical Oncology 25(18S), 2007. e-Pub 2007.
      39. Dalal S. Intravenous Naloxone Utilization among hospitalized cancer patients on Opioids at a Tertiary Cancer Center. MASCC/ISOO 2018 Annual Meeting.
      40. Dalal, S. The impact of race/ethnicity on the prognostic associations between general and visceral obesity and breast cancer outcomes. 10th Cachexia Conference: poster session, Rome.
      41. S Dalal S, A Reddy A, J Arthur J, A Haider A, R Dev R, J Williams J, R Sobti R, K Tanco K, E Bruera E. Frequency and Severity of Pain in Hospitalized Cancer Patients at a Tertiary Cancer Center. Supportive Care Oncology Symposium 2019 San Francisco.

      Book Chapters

      1. Tschanz, JM, Sanchez, EH, Dalal, S. Supportive Care Challenges and Management in Pancreatic Cancer, 159-168, 2023.
      2. Dalal, S. Supportive Care Challenges and Management in Pancreatic Cancer. In: Pancreatic Cancer, Current Therapeutics and Future Directions. 1st. Springer, 2023.
      3. Dalal S. Chapter 24: Docusate and Sennosides for Constipation. In: 50 Palliative Care Studies Every Doctor Should Know. Oxford University Press, 2018.
      4. Dalal S. Chapter 26: Octreotide for Malignant Bowel Obstruction. In: 50 Palliative Care Studies Every Doctor Should Know. Oxford University Press, 2018.
      5. Davis MP, Dalal S, McPherson ML, Sloan PA, Goforth H, Roeland E. UNIPAC 3: Pain Assessment and Management. In: Essential Practices in Hospice and Palliative Medicine, 2018.
      6. Dalal S. Pneumonia. In: Internal Medicine Issues in Palliative Care, 2014.
      7. Dalal S. UTI. In: Internal Medicine Issues in Palliative Care. Oxford University Press, 2014.
      8. Dalal S, Bruera E. Methadone and Buprenorphine Prescribing in the Palliative Care Population. In: Handbook of Methadone Prescribing and Buprenorphine Therapy. Springer, 241-261, 2013.
      9. Dalal S, Bruera E. Principles of Hospice and Palliative Care. In: Oncology for the Primary Care Clinician. Lippincott Williams & Wilkins, 2013.
      10. Dalal S. Chapter 7: Dehydration in Cancer Patients. In: Oxford American Handbook of Hospice and Palliative Medicine. 1. Oxford University Press, 97-103, 2011.
      11. Dalal S. Chapter 10: Chronic Nausea and Vomiting. In: Oxford American Handbook of Hospice and Palliative Medicine. 1. Oxford University Press, 127-138, 2011.
      12. Dalal S, Bruera E. Chapter 15: Cancer Anorexia and Cachexia. In: Supportive Oncology, 1st Edition. 1st. Elsevier Saunders, 151-160, 2011.
      13. Dalal S. Nutritional Management in Recurrent, Advanced or Metastatic Cancer. In: Nutrition and the Cancer Patient. 1st. Oxford University Press, 435-444, 2010.
      14. Dalal S, Palat G, Bruera E. Chronic Nausea and Vomiting. In: Principles and Practice of Palliative Care and Supporting Oncology. 3rd. Lippincott Williams & Wilkins, 151-162, 2007.
      15. Dalal S, Palat G, Bruera E. Management of Dyspnea. In: Principles and Practice of Palliative Care and Supportive Oncology. 3rd. Lippincott Williams & Wilkins, 277-290, 2007.
      16. Dalal S, Zhukovsky DS, Bruera E. Fever and Hot Flashes. In: Palliative Medicine. Edward Arnold Ltd, 2006.
      17. Dalal S, Bruera E. Pathophysiology of chemotherapy induced nausea and emesis: In Chemotherapy Induced Nausea and Emesis. In: Prevention of Chemotherapy Induced Nausea and Vomiting. CMP Healthcare Media, 2004.

      Books (edited and written)

      1. Brueara E, Dalal S. The MD Anderson Supportive and Palliative Care Handbook. Ed(s) 5th. The MD Anderson Cancer Center, 2015.

      Letters to the Editor

      1. Dalal S, Zhukovsky DS. Pathophysiology and management of fever. Journal of Supportive Oncology 4(6), 2006.
      Read More
      Less

      Patient Reviews


      CV information above last modified July 22, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top